News | Heart Valve Technology | September 19, 2016

Valtech Cardio Presents Data on Tricuspid, Mitral Devices at PCR London Valves 2016

Initial clinical experience of several Cardioband Tricuspid implantations and two-year follow-up results of mitral patients to be presented

Valtech Cardio, Cardioband Tricuspid, Cardioband Mitral, PCR London Valves 2016, study data

September 19, 2016 — Valtech Cardio Ltd. announced that it will present the first-in-man data for its Cardioband Tricuspid (TR) system at PCR London Valves 2016, Sept. 18-20. In addition, updated two-year follow-up results of the multi-center Cardioband Mitral study will be presented at the meeting.

“I am pleased to share my first experience with Cardioband Tricuspid, which shows that it is feasible to perform a successful trans-venous surgical like annuloplasty procedure for the treatment of TR.” said Francesco Maisano, M.D, chairman and professor of cardiovascular surgery at The University Hospital of Zurich who successfully performed the first implantation of Cardioband Tricuspid. “The device has the potential to reproduce surgical standards, although our experience is still limited at the moment.”

A Valtech symposium titled, “Cardioband: Clinical Reality for Mitral and Tricuspid Valve Repair,” will be led by Eberhard Grube, M.D., Ph.D., (University of Bonn, Germany) and Karl-Heinz Kuck, M.D. (Asklepios Klinic St. Georg, Hamburg, Germany) Tuesday, Sept. 20. Panelists will discuss how they are successfully using Cardioband to apply the surgical gold standard in a transfemoral approach.

An accepted talk, “Direct annuloplasty - Cardioband in tricuspid regurgitation,” was presented by Prof. K.H. Kuck (Asklepios Klinic St. Georg, Hamburg, Germany) as part of the “innovation in percutaneous tricuspid valve intervention” session Sunday, Sept. 18.

An accepted abstract, "One Year Follow-up Results of Mitral Valve Transcatheter Annuloplasty System for Mitral Reconstruction Multicentre Trial,” will be presented by Prof. R. S. von Bardeleben (University of medicine Mainz Germany) as part of the "Mitral and Tricuspid Valve Interventions" session held Monday, Sept. 19.

An additional accepted abstract, "Cardioband implantation to treat recurrent mitral regurgitation after MitraClip therapy,” will be presented by Dr. M. Taramasso (University Hospital of Zurich) as part of the "Percutaneous mitral therapies" session Tuesday, Sept. 20.

For more information:

Related Content

Biotronik Studies Demonstrate Efficacy of Minimizing Metal Burden in SFA Therapy
News | Stents Bare Metal| September 22, 2017
Physicians demonstrated that reducing metal burden in superficial femoral artery (SFA) therapy could effectively reduce...
Montreal Heart Institute Performs First Robotic Mitral Valve Surgery
News | Robotic Systems| September 22, 2017
The Montreal Heart Institute (MHI) announced the acquisition of the da Vinci Xi, a new-generation surgical robot, and...
Edwards Inspiris Resilia Valve Receives FDA Approval
News | Heart Valve Technology| September 21, 2017
Edwards Lifesciences Corp. recently received U.S. Food and Drug Administration (FDA) approval for its Inspiris Resilia...
MyoKardia Presents Additional Positive Data From Phase 2 PIONEER-HCM Study at HFSA 2017
News | Heart Failure| September 21, 2017
MyoKardia Inc. announced that additional positive data from the first patient cohort of its Phase 2 PIONEER-HCM study...
Tryton Side Branch Stent Recognized With Premier Technology Breakthrough Award
News | Stents Bifurcation| September 21, 2017
September 21, 2017 — Cardinal Health and Tryton Medical Inc.
DISRUPT BTK Study Shows Positive Results With Lithoplasty in Calcified Lesions Below the Knee
News | Peripheral Artery Disease (PAD)| September 20, 2017
Shockwave Medical reported positive results from the DISRUPT BTK Study, which were presented at the annual...
Corindus Announces First Patient Enrolled in PRECISION GRX Registry
News | Robotic Systems| September 18, 2017
September 18, 2017 — Corindus Vascular Robotics Inc.
Two-Year ILLUMENATE Trial Data Demonstrate Efficacy of Stellarex Drug-Coated Balloon
News | Drug-Eluting Balloons| September 18, 2017
Philips announced the two-year results from the ILLUMENATE European randomized clinical trial (EU RCT) demonstrating...
Sentinel Cerebral Protection System Significantly Reduces Stroke and Mortality in TAVR
News | Embolic Protection Devices| September 18, 2017
September 18, 2017 – Claret Medical announced publication of a new study in the...
Fysicon Receives FDA Approval for QMAPP Hemodynamic Monitoring System
Technology | Hemodynamic Monitoring Systems| September 18, 2017
Fysicon announced that it has been granted 510(k) clearance by the U.S. Food and Drug Administration (FDA) for its...
Overlay Init